Enter multiple symbols separated by commas

Stocks Seattle Genetics Inc


  • 7 Cancer Drug Stocks to Know Right Now Wednesday, 14 Mar 2012 | 2:39 PM ET
    Three laboratory technicians using microscope

    Savvy investors know that making money on the “ASCO trade” means getting in early as cancer drug stocks typically trade up into the closely watched medical meeting.

  • 11 Biotech Stocks Hedge Funds Love and Hate Wednesday, 17 Aug 2011 | 12:02 PM ET

    Hedge funds peeled back the curtain this week to reveal a bit about what biotech stocks they were buying and selling during the second quarter.

  • Lightning Round OT: Seattle Genetics, IBM and More Wednesday, 22 Jun 2011 | 8:02 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • The Next Big Thing In the Battle Against Cancer? Monday, 6 Jun 2011 | 1:43 PM ET

    Traders are turning their attention to cancer-fighting companies, as the 2011 ASCO gets underway.

  • Cramer makes the call on viewers' favorite stocks.

  • Cramer makes the call on viewers' favorite stocks.

  • Just Another Manic Monday In Biopharma Monday, 5 Oct 2009 | 11:36 AM ET

    If you were ever needed examples of the phenomenal risk and reward of investing in baby biopharma look no further than what’s going on in the sector today.

  • Sector Trade: Biotech Monday, 28 Sep 2009 | 5:32 PM ET

    Investors are placing their bets on the next M&A deal in biotech. Where should you be looking?

  • Biopharma Gets Its Groove On Thursday, 23 Jul 2009 | 1:42 PM ET

    What a week! And there's still one day left. Human Genome Sciences and Orexigen got the party started on Monday with their Lupus and diet drug data, respectively. Onyx Pharmaceuticals was a surprise guest with its mid-stage breast cancer results on Wednesday. Bristol-Myers Squibb cranked up the volume late yesterday with its two-bagger for Medarex. And then this morning Celgene announced it had stopped a multiple myeloma study early because the drug appears to be working so well.

  • Best Trades Now: Biotech, Energy & Defensive Stocks Wednesday, 11 Jun 2008 | 12:56 PM ET

    With the markets selling off again today, CNBC asked the experts for their best investment ideas now.

  • Lightning Round OT: Annaly Capital and More Tuesday, 18 Mar 2008 | 7:26 PM ET

    The Lightning Round is extended in this new CNBC.com exclusive feature.

  • Biogen Idec: First Of A Biotech Buying Binge? Monday, 15 Oct 2007 | 12:52 PM ET

    For quite some time now analysts and investors have been speculating that big pharma would go on a biotech buying binge. So, will the announcement by Biogen Idec late Friday that it's putting itself on the market be the spark that ignites an M & A explosion in the sector? Perhaps.

  • Healthcare on the Other Hill Monday, 8 Jan 2007 | 2:34 PM ET

    While on Capitol Hill the new Congress begins to take on the pharmaceuticals industry, the healthcare investment community is holding its annual confab in the hills of San Francisco--House Speaker Nancy Pelosi's home district. I'm at the 25th Annual JPMorgan Healthcare Conference at the Westin St. Francis on Union Square. The four-day event is just getting started, but the halls are...